Role of zinc in ALS

Area of Science:

• Neuroscience
• Genetics
• Biochemistry

Background:

• Amyotrophic lateral sclerosis (ALS) causes are largely unknown.
• A small percentage of ALS cases are linked to mutations in the superoxide dismutase (SOD1) gene.
• Mutant SOD1 mice model ALS pathology, exhibiting oxidative stress, excitotoxicity, and neuroinflammation.

Purpose of the Study:

• To investigate the role of zinc ion disposition in the initiation and progression of ALS.
• To explore the connection between SOD1 mutations, zinc binding, and ALS pathogenesis.
• To evaluate the potential of zinc dysregulation in explaining environmental ALS triggers.

Main Methods:

• Analysis of post-mortem human tissue and SOD1-mutant mouse models.
• Examination of pathological processes including oxidative stress, neuroinflammation, and protein aggregation.
• Investigation of metallothionein (MT) expression and its effect on disease progression.

Main Results:

• Mutant SOD1 forms associated with ALS exhibit altered zinc binding.
• Metallothionein (MT) expression is altered in mutant SOD1 mice, and MT deletion accelerates disease.
• Zinc plays a critical role in multiple ALS-associated pathological pathways.

Conclusions:

• Altered zinc ion disposition is proposed as a key factor in ALS initiation and development.
• The zinc hypothesis offers a potential explanation for environmental influences on ALS.
• Targeting zinc dysregulation may present novel therapeutic avenues for ALS.